Meridian Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Meridian Wealth Management, LLC

$2 Billion
Q3 2024

A detailed history of Meridian Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Meridian Wealth Management, LLC holds 1,019 shares of REGN stock, worth $752,022. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,019

Previous 964 5.71%

Holding current value

$752,022

Previous $1.01 Million 5.73%

% of portfolio

0.05%

Previous 0.12%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $56,324 - $66,096	55 Added 5.71%	1,019 $1.07 Million
Q2 2024 Aug 08, 2024	BUY	$883.2 - $1071.19 $851,404 - $1.03 Million	964 New	964 $1.01 Million
Q4 2023 Feb 08, 2024	BUY	$775.18 - $881.7 $70,541 - $80,234	91 Added 10.08%	994 $873,000
Q3 2023 Oct 17, 2023	SELL	$692.45 - $844.37 $2,769 - $3,377	-4 Reduced 0.44%	903 $743,000
Q2 2023 Aug 02, 2023	BUY	$700.03 - $830.35 $59,502 - $70,579	85 Added 10.34%	907 $651,000
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $331,398 - $402,734	487 Added 145.37%	822 $675,000
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $236,473 - $256,740	335 New	335 $241,000
Q4 2020 Jan 19, 2021	SELL	$478.3 - $607.98 $258,282 - $328,309	-540 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$544.75 - $658.21 $563,271 - $680,589	-1,034 Reduced 65.69%	540 $302,000
Q2 2020 Jul 15, 2020	BUY	$493.32 - $643.92 $495,293 - $646,495	1,004 Added 176.14%	1,574 $981,000
Q1 2020 Apr 16, 2020	BUY	$336.18 - $494.43 $191,622 - $281,825	570 New	570 $278,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Management, LLC with notifications on news.

Account

Meridian Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History